CN Bio announces expert speaker line-up and scientific program for inaugural Organ-on-a-chip e-Symposium
Four sessions across twodays focusing on key drug discovery and development application areas of organ-on-a-chip technologies Expert-led presentations and panel discussions featuring leaders across research, regulatory and industry, including Novo
Laverock Therapeutics announces in vivo programmes in oncology and genetic medicine
Laverock's programmable gene control platform unlocks in vivo therapeutics with enhanced efficacy and safety
Cambridge Forum brings global leaders together to turn AI innovation into impact
Cambridge, UK – September 2026: Cambridge Forum brought together around 200 delegates from the UK and overseas at Cambridge Corn Exchange on 10th and 11th September, creating a multidisciplinary meeting place for some of the most pressing conversations around AI, health and the responsible use of technology.
Cytotrait appoints Dr Ian Jepson as Non-Executive Director
Accomplished international R&D executive, previously Syngenta, specialising in biotech trait development and genome editing technologiesFollows £3M seed round in 20261 to expand capabilities of the Company’s core MOSS platform and establish trait enhancem
AstraZeneca announces strategic equity investment and clinical collaboration with Summit Therapeutics to advance leading ADC combination strategy in cancer
Clinical collaboration will evaluate sonesitatug vedotin, a Claudin-18.2 ADC, with ivonescimab, a first-in-class PD-1/VEGF bispecific, in gastrointestinal cancers
Why the Cambridge region is becoming an increasingly important focal point for UK medical technology
The Cambridge region has long been recognised as one of the UK’s strongest centres for science, technology and life sciences. What makes the area particularly interesting for medical technology is the way those disciplines increasingly overlap.
Why omnichannel lead strategies matter in complex B2B markets
Many B2B companies operate across multiple marketing channels, yet prospects often experience those channels as disconnected.
Cambridge Mind and Brain Institute launches to address challenges facing our brain health
Cambridge announces a new institute focused on understanding and improving brain health across our lifespan, from early childhood through to old age.
PhiZ & Co will be at this year’s RAREsummit
On Wednesday 7 October 2026, 300 minds from across the rare disease community will gather at the Wellcome Genome Campus for the 8th RAREsummit – a unique opportunity to make connections, exchange ideas, and openly debate possibilities. If you work in rare disease science, healthcare, research, innovation, policy, funding, advocacy, or live with a rare condition, this is an event not to be missed…
Particle counters – a small change that could have a huge impact on your controlled environment efficiencies
East Anglian contamination control specialists Guardtech urging applications across Life Sciences, High-Tech Engineering and Healthcare to consider positive effects continuous monitoring can have for on-going cleanroom performance as well as operational success
Built by one person, relied on by many: small AI tools in life sciences organisations
By Lily Lin, CEO, Excellence First Enterprise Consultancy.
Astoriom acquires additional UK storage business to expand capacity and service offerings
• Acquisition of Sampled’s UK facility strengthens Astoriom’s position as a trusted provider of secure, compliant and quality-led sample stability and biorepository storage solutions • Offers broader coverage, additional technical expertise and increased operational resilience to help safeguard critical samples
How does lead design affect MRI compatibility?
A smarter way to design MRI-safe implants: Evaluating MRI-induced RF heating earlier with efficient transfer-function modelling
Eppendorf introduces the new SpinPro® 8 R high-speed centrifuge
Eppendorf, a leading international life science company that develops, manufactures, and distributes instruments, consumables, and services for use in laboratories around the world, today announced the expansion of its centrifuge portfolio with the launch of the new SpinPro 8 R, a refrigerated, f
What AI in life sciences looks like up close
Reflections from the Cambridge TechBio Caucus working lunch during Cambridge Tech Week.
The EpiCentre welcomes new cancer diagnostics company 4fold Bioscience
A biotechnology start-up company, developing a low-cost diagnostic platform designed to accurately identify early-stage cancers , has chosen The EpiCentre in Haverhill as the base for its next stage of development
Nuclera appoints Carl Raimond as Chief Executive Officer
Former Olink Proteomics President brings extensive life-science tools leadership experience, having helped lead Olink through its $3.1 billion acquisition by Thermo Fisher Scientific Co-founder and former CEO Dr Michael Chen transitions to Chief Scientific and Busi
ROAR Events Agency and Holiday Inn Cambridge launch a summer party partnership for 2027
Cambridge, UK – September 2026 – ROAR Events Agency has announced a new partnership with Holiday Inn Cambridge to deliver a programme of large-scale corporate summer parties and outdoor events throughout May to September 2027.
CellCentric wins Business of the Year at 36th Business Weekly Awards ahead of tipped US IPO
Tony Quested writes: CEO Will West winged in from New York as his company CellCentric won the 36th annual Business Weekly Awards' coveted Business of the Year crown at Queens' College.
What does it take to build a world-class company in the UK?
The UK has no shortage of great ideas. The harder question is whether we have the capital, people and appetite for risk to turn more of them into world-class companies that grow and stay here.
Big Picture Bio founded to identify, design and optimise promising cancer combination therapies
New company founded by Deep Science Ventures veterans closes £1.5M (~$2M USD) pre-seed round and secures £700K (~$950K USD) Innovate UK fundingFounding team and advisors bring expertise from Deep Science Ventures, AstraZeneca, Exscientia and PhoreMostI
Acquisition of Corazon Health by HCML
Corazon Health announced today that it has been acquired by HCML, a leading provider of health, rehabilitation, case management, and treatment services.
Research Roundup: Summer 2026
Welcome to our new research roundup. Each quarter we will highlight new research publications that include the NIHR BioResource and our participants. We have summarised each publication below, including links to the journal and any associated news articles.
